Promega has announced the release of its COVID-19 serological antibody test, Lumit Dx. The in vitro diagnostic test relies on the company’s bioluminescence technology, which can indicate the presence of coronavirus antibodies in patients’ serum or plasma.

The test is performed on PCR (polymerase chain reaction) confirmed COVID-19 patients who are 20-plus days past the onset of symptoms. The company says that the test offers “a quick and simple workflow” that provides reliable results in under an hour and is scalable for “high-throughput needs.”

Promega has submitted an emergency use authorization (EUA) with the US Food and Drug Administration.